Logo1
American Transplant Congress 2008
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.

Please rate the following questions:

 

   Overall quality of the meeting.

Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
Please rate the expertise of the speaker(s):
   The program was relevant to my work.
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
Please rate the teaching ability of the speaker(s):
   How well were the educational objectives met?
Please rate the organization of materials.
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
Please rate the organization of materials by the speaker(s):
   Usefulness of handouts/AV.

Please rate how well the following objectives were met:

   Discuss basic aspects of alloimmunity and antigen processing.

Please rate how well the following objectives were met:

   Describe measures to prevent post transplant malignancies.

Please rate how well the following objectives were met:

   Describe how to develop a relationship with a referring physician.

Please rate how well the following objectives were met:

   Describe how pre-transplantation eradication of hepatitis C may effectively prevent post-

   transplantation recurrence of disease.

Please rate how well the following objectives were met:

   Discuss the current and upcoming research being conducted at the US Department of Health and

   Human Services, Organ Procurement and Transplant Network, and developing partnerships with

   other government organizations.

Please rate how well the following objectives were met:

   Describe new immunosuppressive agents in kidney transplantation currently in clinical trials.

Please rate how well the following objectives were met:

   List the gold-standard techniques for measurement of GFR and their surrogate markers.

Please rate how well the following objective was met:

   Describe the role of the alloantibody response in clinical transplantation.

Please rate how well the following objective was met:

   Discuss the effect of mTOR inhibition on vascular cell injury and repair.

Please rate how well the following objectives were met:

   List the types of infections transmitted with organs to recipients.

Please rate how well the following objective was met:

   Identify and discuss pancreas transplant categories.

Please rate how well the following objective was met:

   Discuss current issues in Antibody crossmatching.

Please rate how well the following objective was met:

   Discuss Immunologic Monitoring and if the practices and procedures are ready to be used more

   widely.

Please rate how well the following objective was met:

   Discuss the new practices of Gene Silencing And Conditional Gene Expression.

Please rate how well the following objective was met:

   List and discuss the functional and phenotypic characteristics of NK and NKT cells.

Please rate how well the following objective was met:

   Discuss the Challenges and Opportunities in Composite Tissue Allografts.

Please rate how well the following objective was met:

   Discuss the long-term impediments to quality of life in patients undergoing liver transplantation in

   adults and pediatrics recipients.

Please rate how well the following objective was met:

   Provide five reasons for incorporating recommendations and encouragement for physical activity

   following organ transplant.

Please rate how well the following objective was met:

   Discuss whether Solid Organ Transplant Recipients should receive New Interventions For The

   Metabolic Syndrome

Please rate how well the following objective was met:

   Discuss the new practice of Pulsatile Perfusion Of Donor Organs.

Please rate how well the following objective was met:

   Discuss top abstracts presented.

Please rate how well the objective was met.
Please rate how well the objective was met.

Please rate how well the following objective was met.

   Discuss potential controversial areas of donor evaluation and recipient selection in living donor

   liver transplantation.

Please rate how well the following objective was met.

   Identify what constitutes a nanotherapeutic.

Please rate how well the following objective was met.

   Discuss the field of T cell-mediated suppression.

Please rate how well the following objective was met.

   Cite new and current practices to deal with Ischemia reperfusion injury.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Identify the risk factors associated with Hepatocellular Carcinoma.

Please rate how well the following objective was met.

   List reasons for the high incidence of cancer.

Please rate how well the following objective was met.

   Summarize differences between innate and adaptive immunity.

Please rate how well the following objective was met.

   Discuss molecular aspects of the mTOR pathway and why mTOR inhibitors could be useful in the

   prevention and treatment of malignancies that develop, especially in transplant recipients.

Please rate how well the following objective was met.

   Discuss Therapeutic Prospects of Alternate Co-stimulation Pathways.

Please rate how well the following objective was met.

   Discuss the role of dendritic cells in allorecognition.

Please rate how well the following objective was met.

   Discuss the function and problems encountered with Memory T Cells.

Please rate how well the following objective was met.

   Discuss new problems and therapies associated with extended donors in liver transplantation.

Please rate how well the following objective was met.

   Identify appropriate allocation of liver and kidney for patients with combined disease.

Please rate how well the following objective was met.

   Review the constructs that contribute to HRQOL.

Please rate how well the following objective was met.

   Describe exchange donor transplantation programs in Korea and their results.

Please rate how well the following objective was met.

   Identify the barriers to transplantation and review potential solutions.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the objective was met.

Please rate how well the objective was met.

Please rate how well the following objective was met.

   Discuss that biological processes are naturally controlled by microRNAs.

Please rate how well the following objective was met.

   Discuss critical aspects of CKD, its incidence and prevalence.

Please rate how well the following objective was met.

   Describe an experimental protocol that was used in an attempt to induce tolerance following

   organ transplantation.

Please rate how well the following objective was met.

   Discuss the current outcomes of liver transplantation for recipients with HCV.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Explain why individuals deficient in complement develop lupus.

Please rate how well the following objective was met.

   Discuss inducing tolerance to organ transplants in children.

Please rate how well the following objective was met.

   List the requirements for obtaining board certification.

Please rate how well the following objective was met.

   Discuss the application of molecular markers to predict primary graft dysfunction after lung

   transplantation.

Please rate how well the following objective was met.

   Review Mechanistic Insights into Chronic Allograft Vasculopathy.

Please rate how well the following objective was met.

   Review Therapeutic Potential of T Regulatory Cells.

Please rate how well the following objective was met.

   Explain interactions between the innate and the adaptive immune systems.

Please rate how well the following objective was met.

   Discuss problems and therapies used for  Pregnancy after Transplantation.

Please rate how well the following objective was met.

   Review MELD / PELD Inequities and how to improve MELD/PELD scores.

Please rate how well the following objective was met.

   List vaccinations which should ideally be administered or updated before transplant.

Please rate how well the following objective was met.

   Explain the role and value of rituximab.

Please rate how well the following objective was met.

   Identify a complex of findings in patients who develop recurrence of diabetes following kidney-

   pancreas transplant.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the objective was met.

Please rate how well the objective was met.

Please rate how well the objective was met.

Please rate how well the objective was met.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Cite the differences in access to transplantation and transplant outcomes between Canada and

   United States.

Please rate how well the following objective was met.

   Discuss the appropriate development of end points in clinical trials for heart transplantation.

Please rate how well the following objective was met.

   Discuss the current evidence of virus-specific humoral and cellular immune markers in kidney

   transplant patients at risk for polyomavirus BK-associated nephropathy.

Please rate how well the following objective was met.

   Discuss using living donors for liver transplantation.

Please rate how well the following objective was met.

   Review excepted practices of Xenotransplantation.

Please rate how well the following objective was met.

   Discuss ideas on B Cells and how they stop graft acceptance.

Please rate how well the following objective was met.

   Describe the role of chemokines in directing T cells and other leukocyte populations to grafts and

   ischemic tissues.

Please rate how well the following objective was met.

   Discuss the outcomes following heart retransplantation and define predictors of a poor outcome

   following heart retransplantation.

Please rate how well the following objective was met.

   Discuss Non-medical Causes of Renal Allograft Loss.

Please rate how well the following objective was met.

   Discuss rationales for variations in intestinal transplantation, i.e. inclusion of other organs.

Please rate how well the following objective was met.

   Describe how to treat Parasitic infections in Transplant Recipients and Donors.

Please rate how well the following objective was met.

   Identify diseases that recur post-transplantation.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Discuss top abstracts presented.

Please rate how well the following objective was met.

   Review new practices discussed throughout the ATC.

   Comfort of rooms.

   Explain the common mechanisms contributing to graft injury.

   Describe the effects of diabetes on grafts, hepatitis C infection, immunosuppression and the effect of insulin on the liver.

   Discuss the need for waitlist management in liver transplantation including regulatory aspects, medical and clinical review of patients on the liver transplantation waiting list.

   Identify the limitations of HCV treatment in the liver transplant patient awaiting transplantation.

   Discuss the increasing proportion of the kidney wait list that is inactive.

   Identify what recipient factors can maximize donor outcome.

   Evaluate potential therapies for transplantation in the sensitized patient.

If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:

If you answered any of the above questions with 'Below Average' or 'Poor,' please explain:

   Discuss lineage, phenotype, and function of T-regs.

   Discuss current immunosuppression drugs, upcoming immunosuppressive drugs, and how to ease patients into immune tolerance.

   List methods used to monitor patients listed and waiting for kidney transplant.

   List the benefits of induction therapy in patients with HCV infection.

   List achievable donor management targets.

   Discuss a critical definition of tolerance.

If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:

How can this training be improved to impact your competence or practice?

   Define clinical features associated with tolerance.

If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:

   Discuss acceptance criteria, waitlist management, DCD donors and high risk patients in liver, kidney and thoracic transplantation.

   Cite the factors associated with worse outcomes following OLT for patients with HCV infection.

If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:

Additional comments:

If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
If you have additional comments regarding a particular speaker or this session (good or bad), please use the space below:
Mr question